Concentrations of pro-inflammatory cytokines IFN-γ, IL-6, IL-12 and IL-15 in serum and cerebrospinal fluid in patients with neuroborreliosis undergoing antibiotic treatment;Zmiany stȩżenia wybranych cytokin prozapalnych IFN-γ, IL-6, IL-12 i IL-15 w surowicy i płynie mózgowo-rdzeniowym pod wpływem antybiotykoterapll u chorych na neuroborellozȩ

Polski Merkuriusz Lekarski

Volumn 22, Issue 130, 2007, Pages 275-279

  Pancewicz, Sławomir A ^a,b   Kondrusik, Maciej ^a,b   Zajkowska, Joanna ^a,b   Grygorczuk, Sambor ^a,b  

^a Klinika Chorób Zaka nych i Neuroinfekcji   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Borrelia burgdorferi; Neuroborreliosis; Pro inflammatory cytokines

Indexed keywords

ANTIINFECTIVE AGENT; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 6;

ADULT; ARTICLE; BLOOD; BORRELIA BURGDORFERI; CASE CONTROL STUDY; CEREBROSPINAL FLUID; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HUMAN; LYME DISEASE; MALE; MIDDLE AGED;

ADULT; ANTI-INFECTIVE AGENTS; BORRELIA BURGDORFERI; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-15; INTERLEUKIN-6; LYME NEUROBORRELIOSIS; MALE; MIDDLE AGED;

EID: 34249704501     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Altare F., Durandy A., Lammas D. i wsp.: Inherited interleukin-12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. J. Clin. Invest., 1998, 102, 2035-2040.
2. Anguita J., Persing D. H., Rincon M. i wsp.: Effect of anti-interleukin12 treatment on murine Lyme borreliosis. J. Clin. Investig., 1996, 97, 1028-1034.
3. Barthold S.W., Beck D.S., Hansen G.M. i wsp.: Lyme borreliosis in select strains and ages of laboratory mice. J. Infect. Dis., 1990, 162, 133-138.
4. Beuche W., Siever A., Felgenhauer K.: Specific antigen binding by activated cerebrospinal fluid B lymphocytes in acute neuroborreliosis. J. Neurol., 1992, 239, 322-326.
5. Cadavid D., O'Neill T., Schaefer H. i wsp.: Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of Lyme Disease. Laborat. Invest., 2000, 80, 1043-1054.
6. Diterich I., Rauter C., Kirschning G.J. i wsp.: Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression. Infect. Immun., 2003, 71, 3979-3987.
7. Ekerfelt C., Ernerudh J., Forsberg P. i wsp.: Augmented inthrathecal secretion of interferon-gamma in response to Borrelia garinii in neuroborreliosis. J. Neuroimmunol., 1998, 89, 177-181.
8. Esche C., Shurin M.R., Lotze M.T.: II-12 in Cytokine Reference. A compedium of cytokines and other mediators of host defence. Oppenheimm J.J., Feldman M.(ed.), Academic Press, London 2000, 187-201.
9. Garcia-Monco J.C., Benach J.L.: Mechanism of injury in Lyme neuroborreliosis. Semin. Neural., 1997, 17, 57-62.
10. Gazzinelli R.T., Hieny S., Wynn T. A. i wsp.: Interteukin-12 is required for the T-lymphocyte-independent induction of Interferon gamma by an intracellular parasite and induces resistance in T cell-deficient hosts. Proc. Natl. Acad. Sci., USA, 1993, 90, 6115-3119.
11. Georgillis K., Peacocke M., Klempner M.S.: Fibroblast protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitro. J. Infect. Dis., 1992, 166, 440-444.
12. Girschick H.J., Meister S., Karch H. i wsp.: Borrelia burgdorferi down regulates ICAM-1 on human synovial cells in vitro. Cell. Adhes. Commun., 1999, 7, 73-84.
13. Habich G.S., Katona L.I., Benach J.L.: Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6. J. Infect. Dis., 1991, 164, 568-574.
14. Isogai E., Isogai H., Kimura K. i wsp.: Cytokines in the serum and brain in mice infected with distinct species of Lyme disease Borrelia. Microb. Pathol., 1996, 21, 413-419.
15. Jabłońska E., Marcińczyk M., Izycka A. i wsp.: IL-15 in the culture supernatants of PMN and PBMC and the serum of patients with Lyme disease. Rocz. Akad. Med. w Białymstoku, 2003, 48, 78-81.
16. Kaiser R.: Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients. J. Neural., 1994, 242, 26-36.
17. Koch F., Stanzl U., Jennewein P. i wsp.: High level IL-12 production by marine dendritic cells: upregulatlon via MHC class II and CD40 molecules and down regulation by IL-4 and IL-10. J. Exp. Med., 1996, 184, 741-746.
18. Kondrusik M., Świerzbińska R., Pancewicz S. i wsp.: Ocena stȩżeń wybranych cytokin prozapalnych: TNF-α, IL-1β, IL-6 oraz IFN-γ w płynie mózgowo-rdzeniowym i surowicy u chorych na neuroboreliozé. Neurol. Neurochirurg. Pol., 2004, 38, 265-270.
19. Kondrusik M., Świerzbińska R., Zajkowska J.M. i wsp.: Wpływ antybiotykoterapii na stȩżenie cytokin prozapalnych: Interleukin IL-1, IL-6 oraz czynnika martwicy nowotworów TNF-alfa w surowicy chorych z borelioza̧ z Lyme. Wiad. Lek., 2002, 40, 276-281.
20. Lebech A.M., Hansen K., Wilske B. i wsp.: "Taxonomic classification of 29 Borrelia burgdorferi strains isolated from patients with Lyme borreliosis: a comparison of five different phenotypic and genotypic typing schemes. Med. Microbiol. Immunol., Berlin 1994, 183, 325-341.
21. Lisinski, T.J., Furie M.B.: lnterleukin-10 inhibits proinflammatory activation of endothelium in response to Borrelia burgdorferi or lipopolysaccharide but not interleukin-1beta or tumor necrosis factor alpha. J. Leukoc. Biol., 2002, 72, 503-511.
22. Marcińczyk M., Jabłońska E., Puzewska W. i wsp.: Effect of rhIL-15 on TLR2 expression and apoptosis of PMN from patients with Lyme disease. Med. Dosw. Mikrobiol., 2005, 57, 85-91.
23. Pachner A.R., Amemiya K., Delaney E. i wsp.: Interleukin-6 is expressed at high levels in the CNS in Lyme Neuroborreliosis. Neurology, 1997, 49, 147-152.
24. Reiner S. L., Zheng S., Wang Z. i wsp.: Leishmania promastigotes evade interleukin-12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J. Exp. Med., 1994, 179, 447-456.
25. Silberer, M., Koszik F., Stingl G. i wsp.: Down regulation of class II molecules on epidermal Langerhans cells in Lyme borreliosis. Br. J. Dermatol., 2000, 143, 786-794.
26. Waldman T.A., Tagaya Y.: 11-15 in Cytokine Reference. A compedium of cytokines and other mediators of host defence. Oppenheimm J.J., Feldman M.(ed., Academic Pres, London 2000, 213-223.
27. Wang G., van Dam A. P., Schwartz I. i wsp.: Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin. Microbiol. Rev., 1999, 12, 633-653.
28. Wooten R.M., Modur V.R., McIntyre T.M. i wsp.: Borrelia burgdorferi outer membrane protein A induces nuclear tranlocation of nuclear factor-κB and inflammatory activation in human endothelial cells. J. Immunol., 1996, 157, 4584-4590.